Mediators of Inflammation

Mediators of Inflammation in Obesity and Its Co-Morbidities


Publishing date
01 Jul 2010
Status
Published
Submission deadline
01 Jan 2010

Lead Editor

1Laboratory of Neuro Endocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID LAB), Santiago University Clinical Hospital, Research Area, Laboratory 9, 15706 Santiago de Compostela, Spain

2Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA

3Department of Endocrinology and Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, 31008 Pamplona, Spain

4Obesity Biology Research Unit, School of Clinical Sciences, University of Liverpool, Duncan Building, Liverpool L69 3GA, UK


Mediators of Inflammation in Obesity and Its Co-Morbidities

Description

Obesity is a chronic metabolic condition with important public health implications. It is associated with a high risk of cardiovascular disease, insulin resistance, hypertension, and other comorbidities. Several authors have suggested that inflammation may be the link among obesity, type 2 diabetes, cardiovascular disease, and abnormalities of innate and adaptive immune function. Indeed, both clinical and experimental observations demonstrate a strong correlation between systemic markers of inflammation and the most serious comorbidities in obesity.

We invite authors to present original research articles as well as review articles that will stimulate the continuing efforts in defining the role of mediators of inflammation in obesity and related comorbidities. Papers with additional and compelling mechanistic evidence linking the pathogenesis of obesity-related diseases are very welcome.

We are also interested in manuscripts that report the clinical applications of approved or investigational antiobesity drugs with emphasis on efficacy, toxicity, response assessment, multimodality treatment, prognostic factors, and predictive markers.

Potential topics include, but are not limited to:

  • Therapeutic instruments targeting obesity and inflammation in humans
  • Obesity and inflammation integration of metabolic and immune response
  • Obesity, inflammation, and metabolic diseases
  • Cross-talk between adipose tissue and immune system
  • Adipokines in the immune-stress response: impact of weight loss
  • The adipocytes and other cellular mediators in obesity and inflammation
  • The role of TLR and NFkB route in obesity and inflammation
  • Oxidative stress in obesity and diabetes
  • The effect of aging on obesity and inflammatory status
    • Novel inflammation-related adipokines and other adipose tissue-derived inflammatory factors
    • Endoplasmic reticulum stress, hypoxia, and other potential mechanisms underlying inflammation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/mi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 239126
  • - Editorial

Mediators of Inflammation in Obesity and Its Comorbidities

Oreste Gualillo
  • Special Issue
  • - Volume 2010
  • - Article ID 473540
  • - Clinical Study

Relevance of Serum Leptin and Leptin-Receptor Concentrations in Critically Ill Patients

Alexander Koch | Ralf Weiskirchen | ... | Frank Tacke
  • Special Issue
  • - Volume 2010
  • - Article ID 535918
  • - Review Article

Inflammation, a Link between Obesity and Cardiovascular Disease

Zhaoxia Wang | Tomohiro Nakayama
  • Special Issue
  • - Volume 2010
  • - Article ID 149678
  • - Research Article

Effect of Moderate-Intensity Exercise on Plasma C-Reactive Protein and Aortic Endothelial Function in Type 2 Diabetic Mice

Nada Sallam | Majid Khazaei | Ismail Laher
  • Special Issue
  • - Volume 2010
  • - Article ID 289645
  • - Review Article

Chronic Inflammation in Obesity and the Metabolic Syndrome

Rosário Monteiro | Isabel Azevedo
  • Special Issue
  • - Volume 2010
  • - Article ID 802078
  • - Review Article

The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases

Carmela Rita Balistreri | Calogero Caruso | Giuseppina Candore
  • Special Issue
  • - Volume 2010
  • - Article ID 784343
  • - Research Article

Leptin Administration Downregulates the Increased Expression Levels of Genes Related to Oxidative Stress and Inflammation in the Skeletal Muscle of ob/ob Mice

Neira Sáinz | Amaia Rodríguez | ... | Gema Frühbeck
  • Special Issue
  • - Volume 2010
  • - Article ID 174341
  • - Review Article

Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

Giovanni Anfossi | Isabella Russo | ... | Mariella Trovati
  • Special Issue
  • - Volume 2010
  • - Article ID 592760
  • - Research Article

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)

Liliana Ferreira | Edite Teixeira-de-Lemos | ... | Flávio Reis
  • Special Issue
  • - Volume 2010
  • - Article ID 792393
  • - Review Article

Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus

Inge A. M. van den Oever | Hennie G. Raterman | ... | Suat Simsek
Mediators of Inflammation
 Journal metrics
Acceptance rate36%
Submission to final decision53 days
Acceptance to publication29 days
CiteScore6.000
Impact Factor3.758
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.